Bilaketaren emaitzak - Ryo Nishikawa

Findu emaitzak
  1. 1
    Standard Therapy for Glioblastoma- A Review of Where We Are

    Standard Therapy for Glioblastoma- A Review of Where We Are nork Ryo Nishikawa

    Argitaratua 2010
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Critical review of the addition of tumor treating fields (TTFields) to the existing standard of care for newly diagnosed glioblastoma patients

    Critical review of the addition of tumor treating fields (TTFields) to the existing standard of care for newly diagnosed glioblastoma patients nork Minesh P. Mehta, Patrick Y. Wen, Ryo Nishikawa, David A. Reardon, Katherine B. Peters

    Argitaratua 2017
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Spinal cord hemangioblastomas in von Hippel–Lindau disease

    Spinal cord hemangioblastomas in von Hippel–Lindau disease nork Hiroshi Kanno, I. Yamamoto, Ryo Nishikawa, M Matsutani, Toshihiko Wakabayashi, Junji Yoshida, Nobuyuki Shitara, Ichiro Yamasaki, Taro Shuin

    Argitaratua 2008
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  4. 4
    A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.

    A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. nork Ryo Nishikawa, Xiang-Dong Ji, R. Christopher Harmon, Cheri S. Lazar, Gordon N. Gill, Webster K. Cavenee, Hongyi Huang

    Argitaratua 1994
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Safety and efficacy of tumour-treating fields (TTFields) therapy for newly diagnosed glioblastoma in Japanese patients using the Novo-TTF System: a prospective post-approval study

    Safety and efficacy of tumour-treating fields (TTFields) therapy for newly diagnosed glioblastoma in Japanese patients using the Novo-TTF System: a prospective post-approval study nork Ryo Nishikawa, Fumiyuki Yamasaki, Yoshiki Arakawa, Yoshihiro Muragaki, Yoshitaka Narita, Shota Tanaka, Shigeru Yamaguchi, Akitake Mukasa, Masayuki Kanamori

    Argitaratua 2023
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Bevacizumab, temozolomide, and radiotherapy for newly diagnosed glioblastoma: comprehensive safety results during and after first-line therapy

    Bevacizumab, temozolomide, and radiotherapy for newly diagnosed glioblastoma: comprehensive safety results during and after first-line therapy nork Frank Saran, Olivier Chinot, Roger Henriksson, Warren Mason, Wolfgang Wick, Timothy F. Cloughesy, Sunita Dhar, Emanuela Pozzi, Josep Garcia, Ryo Nishikawa

    Argitaratua 2016
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma

    Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma nork Wolfgang Wick, Olivier Chinot, Martin Bendszus, Warren Mason, Roger Henriksson, Frank Saran, Ryo Nishikawa, Cédric Révil, Yannick Kerloëguen, Timothy F. Cloughesy

    Argitaratua 2016
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Prognostic Impact of No-Flow Time on 30-Day Neurological Outcomes in Patients With Out-of-Hospital Cardiac Arrest Who Received Extracorporeal Cardiopulmonary Resuscitation

    Prognostic Impact of No-Flow Time on 30-Day Neurological Outcomes in Patients With Out-of-Hospital Cardiac Arrest Who Received Extracorporeal Cardiopulmonary Resuscitation nork Naoto Murakami, Nobuaki Kokubu, Nobutaka Nagano, Jun‐ichi Nishida, Ryo Nishikawa, Jun Nakata, Yohei Suzuki, Kazufumi Tsuchihashi, Eichi Narimatsu, Tetsuji Miura

    Argitaratua 2020
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Up-Regulation of Angiopoietin-2, Matrix Metalloprotease-2, Membrane Type 1 Metalloprotease, and Laminin 5 γ 2 Correlates with the Invasiveness of Human Glioma

    Up-Regulation of Angiopoietin-2, Matrix Metalloprotease-2, Membrane Type 1 Metalloprotease, and Laminin 5 γ 2 Correlates with the Invasiveness of Human Glioma nork Ping Guo, Yorihisa Imanishi, Frank C. Cackowski, Michael J. Jarzynka, Huo-Quan Tao, Ryo Nishikawa, Takanori Hirose, Bo Hu, Shi‐Yuan Cheng

    Argitaratua 2005
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Significance of <i>IDH</i> mutations varies with tumor histology, grade, and genetics in Japanese glioma patients

    Significance of <i>IDH</i> mutations varies with tumor histology, grade, and genetics in Japanese glioma patients nork Akitake Mukasa, Shunsaku Takayanagi, Kuniaki Saito, Junji Shibahara, Yusuke Tabei, Kazuhide Furuya, Takafumi Ide, Yoshitaka Narita, Ryo Nishikawa, Keisuke Ueki, Nobuhito Saito

    Argitaratua 2011
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Upfront bevacizumab may extend survival for glioblastoma patients who do not receive second-line therapy: an exploratory analysis of AVAglio

    Upfront bevacizumab may extend survival for glioblastoma patients who do not receive second-line therapy: an exploratory analysis of AVAglio nork Olivier Chinot, Ryo Nishikawa, Warren Mason, Roger Henriksson, Frank Saran, Timothy F. Cloughesy, Josep Garcia, Cédric Révil, Lauren E. Abrey, Wolfgang Wick

    Argitaratua 2016
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway

    Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway nork Bo Hu, Ping Guo, Ifat Bar-Joseph, Yorihisa Imanishi, Michael J. Jarzynka, Oliver Bögler, Tom Mikkelsen, Takanori Hirose, Ryo Nishikawa, Shi‐Yuan Cheng

    Argitaratua 2007
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Comparison on epidemiology, tumor location, histology, and prognosis of intracranial germ cell tumors between Mayo Clinic and Japanese consortium cohorts

    Comparison on epidemiology, tumor location, histology, and prognosis of intracranial germ cell tumors between Mayo Clinic and Japanese consortium cohorts nork Hirokazu Takami, Avital Perry, Christopher S. Graffeo, Caterina Giannini, Yoshitaka Narita, Yoichi Nakazato, Nobuhito Saito, Ryo Nishikawa, Masao Matsutani, Koichi Ichimura, David J. Daniels

    Argitaratua 2020
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Phase II Study of Single-agent Bevacizumab in Japanese Patients with Recurrent Malignant Glioma

    Phase II Study of Single-agent Bevacizumab in Japanese Patients with Recurrent Malignant Glioma nork Motoo Nagane, Ryo Nishikawa, Yusuke Narita, H. Kobayashi, Shingo Takano, Nobusada Shinoura, Taku Aoki, Keiji Sugiyama, J. Kuratsu, Yoshihiro Muragaki, Yasuo Sawamura, Masao Matsutani

    Argitaratua 2012
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Three-year follow-up analysis of phase 1/2 study on tirabrutinib in patients with relapsed or refractory primary central nervous system lymphoma

    Three-year follow-up analysis of phase 1/2 study on tirabrutinib in patients with relapsed or refractory primary central nervous system lymphoma nork Hajime Yonezawa, Yoshitaka Narita, Motoo Nagane, Kazuhiko Mishima, Yasuhito Terui, Yoshiki Arakawa, Katsunori Asai, Noriko Fukuhara, Kazuhiko Sugiyama, Naoki Shinojima, Arata Aoi, Ryo Nishikawa

    Argitaratua 2024
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Genome‐wide identification of genes with amplification and/or fusion in small cell lung cancer

    Genome‐wide identification of genes with amplification and/or fusion in small cell lung cancer nork Reika Iwakawa, Masataka Takenaka, Takashi Kohno, Yoko Shimada, Yasushi Totoki, Tatsuhiro Shibata, Koji Tsuta, Ryo Nishikawa, Masayuki Noguchi, Aiko Sato‐Otsubo, Seishi Ogawa, Jun Yokota

    Argitaratua 2013
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    SHP-2/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A/ARF aberrations in mice and humans

    SHP-2/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A/ARF aberrations in mice and humans nork Kun-Wei Liu, Haizhong Feng, Robert Bachoo, Andrius Kazlauskas, Erin Smith, Karen Symes, Ronald L. Hamilton, Motoo Nagane, Ryo Nishikawa, Bo Hu, Shi-Yuan Cheng

    Argitaratua 2011
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    The Enhanced Tumorigenic Activity of a Mutant Epidermal Growth Factor Receptor Common in Human Cancers Is Mediated by Threshold Levels of Constitutive Tyrosine Phosphorylation and Unattenuated Signaling

    The Enhanced Tumorigenic Activity of a Mutant Epidermal Growth Factor Receptor Common in Human Cancers Is Mediated by Threshold Levels of Constitutive Tyrosine Phosphorylation and... nork Hongyi Huang, Motoo Nagane, Candice K. Klingbeil, Hong Lin, Ryo Nishikawa, Xiang-Dong Ji, Chun‐Ming Huang, Gordon N. Gill, H Wiley, Webster K. Cavenee

    Argitaratua 1997
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    ELMO1 and Dock180, a Bipartite Rac1 Guanine Nucleotide Exchange Factor, Promote Human Glioma Cell Invasion

    ELMO1 and Dock180, a Bipartite Rac1 Guanine Nucleotide Exchange Factor, Promote Human Glioma Cell Invasion nork Michael J. Jarzynka, Bo Hu, Kwok-Min Hui, Ifat Bar-Joseph, Weisong Gu, Takanori Hirose, Lisa B. Haney, Kodi S. Ravichandran, Ryo Nishikawa, Shi‐Yuan Cheng

    Argitaratua 2007
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Using artificial intelligence to improve human performance: efficient retinal disease detection training with synthetic images

    Using artificial intelligence to improve human performance: efficient retinal disease detection training with synthetic images nork Hitoshi Tabuchi, Justin Engelmann, Fumiatsu Maeda, Ryo Nishikawa, Toshihiko Nagasawa, Tomofusa Yamauchi, Mao Tanabe, Masahiro Akada, Keita Kihara, Yasuyuki Nakae, Yoshiaki Kiuchi, Miguel O. Bernabéu

    Argitaratua 2024
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: